Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Bader-Meunier

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Arthritis Research & Therapy|December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registriesJoost Swart, Gabriella Giancane, Gerd Horneff, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Journal of Clinical Immunology|August 28, 2024
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System InflammationClément Triaille, Neha Mohan Rao, Gillian I Rice, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Journal of the American Academy of Dermatology|August 13, 2022
Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter studyLaurye-Anne Eveillard, Pierre Quartier, Naim Ouldali, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Journal of Autoimmunity|April 9, 2026
Takayasu arteritis phenotypes and outcomes: A data-driven cluster analysis from a large international cohortMatheus Vieira, Elie Ghayad, Florence A Aeschlimann, et al.
Joint Bone Spine|January 1, 2017
Familial and syndromic lupus share the same phenotype as other early-onset forms of lupusOlivia Weill, Stéphane Decramer, Christophe Malcus, et al.
Environmental Microbiology|September 6, 2022
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age childrenAgnes Delaunay-Moisan, Tiffany Guilleminot, Michaela Semeraro, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Arthritis Research & Therapy|December 28, 2018
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registriesJoost Swart, Gabriella Giancane, Gerd Horneff, et al.
Seminars in Arthritis and Rheumatism|July 20, 2014
Association of mastocytosis with inflammatory joint diseases: a series of 31 patientsBrigitte Bader-Meunier, Cristina Bulai Livideanu, Claire Larroche, et al.
Journal of Clinical Immunology|August 28, 2024
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System InflammationClément Triaille, Neha Mohan Rao, Gillian I Rice, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Journal of the American Academy of Dermatology|August 13, 2022
Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter studyLaurye-Anne Eveillard, Pierre Quartier, Naim Ouldali, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 childrenMarie-Louise Frémond, Mathieu Paul Rodero, Nadia Jeremiah, et al.
Journal of Autoimmunity|April 9, 2026
Takayasu arteritis phenotypes and outcomes: A data-driven cluster analysis from a large international cohortMatheus Vieira, Elie Ghayad, Florence A Aeschlimann, et al.
Joint Bone Spine|January 1, 2017
Familial and syndromic lupus share the same phenotype as other early-onset forms of lupusOlivia Weill, Stéphane Decramer, Christophe Malcus, et al.
Environmental Microbiology|September 6, 2022
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age childrenAgnes Delaunay-Moisan, Tiffany Guilleminot, Michaela Semeraro, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
Pageof 24